Bioline RX

BLRX

Forecast & Rating2 analysts currently cover Bioline RX, of which 1 give a positive rating. The average price target is $22.00, about 994.5% upside from the current price of $2.01. Coverage is limited, so the data is for reference only. Data as of Oct 25, 2026; this does not constitute investment advice.

Oct 23, 2026
Price forecast
$22.00994.53%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Target price forecast

Forecast dateOct 26, 2026
Forecast met0.0%
Stock price$2.01
Avg. target$20.3
High target$26
Low target$12
18-month Forecast03/21/202210/26/2026

Analyst ratings

Strong buy
Buy
Hold
Sell
Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.